Tralokinumab as an effective alternative after dupilumab treatment failure in moderate-to- severe atopic dermatitis: A real- world study

被引:1
|
作者
George, Shaina E. [1 ]
Yu, Jiade [2 ]
机构
[1] CUNY, SCH MED, NEW YORK, NY USA
[2] Harvard Med Sch, Massachusetts Gen Hosp, Dept Dermatol, Boston, MA USA
关键词
atopic dermatitis; contact dermatitis; drugs; eczema; immunobiologics;
D O I
10.1016/j.jaad.2024.08.019
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
引用
收藏
页码:1228 / 1230
页数:3
相关论文
共 50 条
  • [1] Effectiveness of abrocitinib for the treatment of moderate-to-severe atopic dermatitis in patients switched from dupilumab and/or tralokinumab: A real-world retrospective study
    Keow, Samantha
    Abu-Hilal, Mohannad
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2024, 91 (04) : 734 - 735
  • [2] Real-world experience of dupilumab in the treatment of moderate-to-severe atopic dermatitis
    Kim, Nicole S.
    Maliyar, Khalad
    Oliveira, Luciana
    O'Toole, Ashley
    Gooderham, Melinda J.
    INTERNATIONAL JOURNAL OF DERMATOLOGY, 2020, 59 (10) : E361 - E363
  • [3] Retrospective Study of Dupilumab Treatment for Moderate to Severe Atopic Dermatitis in Korea: Efficacy and Safety of Dupilumab in Real-World Practice
    Jang, Dong Hyek
    Heo, Seok Jae
    Jung, Hye Jung
    Park, Mi Yeon
    Seo, Seong Jun
    Ahn, Jiyoung
    JOURNAL OF CLINICAL MEDICINE, 2020, 9 (06) : 1 - 12
  • [4] Atopic dermatitis: real-life experience with tralokinumab after dupilumab failure: a case series
    Amoedo, Patricia
    Rosa, Gilberto
    Baudrier, Teresa
    Pedrosa, Ana Filipa
    Cruz, Maria Joao
    ANAIS BRASILEIROS DE DERMATOLOGIA, 2024, 99 (05) : 721 - 724
  • [5] Dupilumab in the treatment of moderate-to-severe atopic dermatitis
    Kraft, Magdalena
    Worm, Margitta
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2017, 13 (04) : 301 - 310
  • [6] Dupilumab for the treatment of moderate and severe atopic dermatitis: real-life experience
    Sroka-Tomaszewska, Jowita
    Bulinska, Barabara
    Wilkowska, Aleksandra
    Nowicki, Roman J.
    Trzeciak, Magdalena
    POSTEPY DERMATOLOGII I ALERGOLOGII, 2023, 40 (06): : 747 - 752
  • [7] Efficacy of tralokinumab after failure with upadacitinib and dupilumab in a patient affected by atopic dermatitis
    Mastorino, L.
    Gelato, F.
    Quaglino, P.
    Ortoncelli, M.
    Ribero, S.
    JOURNAL OF DERMATOLOGICAL TREATMENT, 2023, 34 (01)
  • [8] Effectiveness and tolerance of tralokinumab after failure with dupilumab and baricitinib in a patient with atopic dermatitis
    Freitas, Egidio
    Yilmaz, Orhan
    Torres, Tiago
    EUROPEAN JOURNAL OF DERMATOLOGY, 2024, 34 (05) : 551 - 553
  • [9] Efficacy and safety of dupilumab in pediatric patients with moderate to severe atopic dermatitis: a real-world study
    Dan-Yang Yang
    Li Li
    Tao Lu
    Wen-Wen Jing
    Xin Liu
    Xiao-Li Li
    Archives of Dermatological Research, 2023, 315 : 467 - 472
  • [10] Efficacy and safety of dupilumab in pediatric patients with moderate to severe atopic dermatitis: a real-world study
    Yang, Dan-Yang
    Li, Li
    Lu, Tao
    Jing, Wen-Wen
    Liu, Xin
    Li, Xiao-Li
    ARCHIVES OF DERMATOLOGICAL RESEARCH, 2023, 315 (03) : 467 - 472